Demonstrating bioequivalence using clinical endpoint studies.

about

Demonstrating comparative in vitro bioequivalence for animal drug products through chemistry and manufacturing controls and physicochemical characterization: a proposal.

P2860

Q41547242-60EDCE95-B3F7-4C02-A922-CE7838B44A60

P2860

Demonstrating bioequivalence using clinical endpoint studies.

Item

http://www.wikidata.org/entity/Q39639394

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Demonstrating bioequivalence using clinical endpoint studies.

@en

Demonstrating bioequivalence using clinical endpoint studies.

@nl

type

Item

label

Demonstrating bioequivalence using clinical endpoint studies.

@en

Demonstrating bioequivalence using clinical endpoint studies.

@nl

prefLabel

Demonstrating bioequivalence using clinical endpoint studies.

@en

Demonstrating bioequivalence using clinical endpoint studies.

@nl

P1476

Demonstrating bioequivalence using clinical endpoint studies.

@en

P2093

C Lainesse

http://www.w3.org/2001/XMLSchema#string

E Bermingham

http://www.w3.org/2001/XMLSchema#string

J R E Del Castillo

http://www.w3.org/2001/XMLSchema#string

K Pasloske

http://www.w3.org/2001/XMLSchema#string

S Radecki

http://www.w3.org/2001/XMLSchema#string

P2860

Modeling of dose-response-time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles.

Simulation of clinical trials.

Clinical trial simulation: a review.

Interindividual variability in plasma concentrations after systemic exposure of swine to dietary doxycycline supplied with and without paracetamol: a population pharmacokinetic approach.

Learning versus confirming in clinical drug development.

Veterinary drug bioequivalence determination.

A novel USP apparatus 4 based release testing method for dispersed systems.

A simulation study comparing designs for dose ranging.

Optimisation of sampling windows design for population pharmacokinetic experiments.

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of ectoparasiticides against biting lice, sucking lice and sheep keds on ruminants.

P304

31-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2885.2012.01366.X

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22413789

http://www.w3.org/2001/XMLSchema#string

Demonstrating bioequivalence using clinical endpoint studies.

about

P2860

P2860

Demonstrating bioequivalence using clinical endpoint studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698